Rick E. Winningham - 20 May 2021 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Chief Executive Officer, Director
Signature
Brett A. Grimaud, Attorney-in-Fact.
Issuer symbol
TBPH
Transactions as of
20 May 2021
Net transactions value
-$202,991
Form type
4
Filing time
24 May 2021, 18:19:33 UTC
Next filing
02 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $202,991 -11,404 -0.85% $17.80 1,324,818 20 May 2021 Direct F1
holding TBPH Ordinary Shares 92,567 20 May 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.